Pulmonary tuberculosis in Norwegian patients. The role of reactivation, re-infection and primary infection assessed by previous mass screening data and restriction fragment length polymorphism analysis

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 4, 2000, Pages 300-307

  Heldal, Einar ^a,c   Docker H ^a   Caugant, D A ^b   Tverdal, A ^a  

^a National Health Screening Service   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c National Health Screening Service   (Norway)

Author keywords

Epidemiology; Molecular epidemiology; RFLP; Tuberculosis

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PRIMARY INFECTION; PRIORITY JOURNAL; REGISTER; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THORAX RADIOGRAPHY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DNA, BACTERIAL; FEMALE; HUMANS; INFANT; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NORWAY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; RECURRENCE; REGISTRIES; REPRODUCIBILITY OF RESULTS; TUBERCULOSIS, PULMONARY;

EID: 0343134010     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Styblo K. Epidemiology of tuberculosis. The Netherlands; KNCV Selected papers Vol 24, 1994.
2. Canetti G, Sutherland I, Svandova E. Endogenous reactivation and exogenous reinfection. Their relative importance with regard to the development of non-primary tuberculosis. Bull Int Union Tuberc 1972; 47(1): 116-134.
3. Sutherland I. Recent studies in the epidemiology of tuberculosis, based upon the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63.
4. Van Soolingen D. Utility of molecular epidemiology of tuberculosis [Editorial]. Eur Respir J 1998; 11: 795-797.
5. Cohn D L, O'Brien R J. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis 1998; 2: 16-26.
6. Van Soolingen D. Use of DNA fingerprinting in the epidemiology of tuberculosis (dissertation). Utrecht, the Netherlands: University of Utrecht, 1996.
7. Diaz R, Kremer K, de Haas P E, et al. Molecular epidemiology of tuberculosis in Cuba outside of Havana, July 1994-June 1995: utility of spoligotyping versus IS6110 restriction fragment length polymorphism. Int J Tuberc Lung Dis 1998; 2: 743-750.
8. Heldal E, Bjartveit K, Tverdal A. Utviklingen av tuberkulose i Norge - har nedgangen stanset? (Trend in tuberculosis in Norway - has the decline stopped?) Tidsskr Nor Laegeforen 1995; 115: 3390-3393 (in Norwegian with English summary).
9. MSIS-rapport 21/1998 (in Norwegian). Reporting system for communicable diseases. National Institute of Public Health. Oslo, Norway.
10. Bauer J, Yang Z, Poulsen S, Andersen A B. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium tuberculosis complex isolates in a country with a low incidence of M. Tuberculosis infection. J Clin Microbiol 1998; 36: 305-308.
11. NOU 1998:3 Utryddelse av tuberkulose? - Strategi for fremtidig tuberkulosekontroll (Elimination of tuberculosis? - Strategy for future tuberculosis control). Statens forvaltningstjeneste. Oslo 1998 (in Norwegian).
12. Bjartveit K. The tuberculosis situation in Norway. Scand J Respir Dis 1978; 59 (Suppl 102): 28-34.
13. Waaler H T. Selective case-finding by a mass radiography service. Tubercle 1965; 46: 85-90.
14. Bjartveit K. Mass miniature radiography in Norway, today and in the future. Scand J Respir Dis 1972; (Suppl 80): 31-42.
15. Waaler H T, Gaining O, Mordal K. The risk of tuberculous infection in Norway. Tuberculosis Surveillance Research Unit Report No.3. Bull Int Union Tuberc 1975; 50: 5-61.
16. Van Embden J D A, Cave M D, Crawford J T, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993; 31: 406-409 .
17. Caugant D, Sandven P, Heldal E. Four years of molecular epidemiology of M. tuberculosis in Norway. Int J Tuberc Lung Dis 1998; 2 (Suppl 2): S279.
18. Barnett G D, Grzybowski S, Styblo K. Present risk of developing active tuberculosis in Saskatchewan according to previous tuberculin and X-ray status. Bull Int Union Tuberc 1971; 45: 51-74.
19. Pfyffer G E, Strassle A, Rose N, Wirth R, Brandli O, Shang H. Transmission of tuberculosis in the metropolitan area of Zurich: a 3-year survey based on DNA fingerprinting. Eur Respir J 1998; 11: 804-808.
20. Garzelli C, Lari N, Nguon B, Pistello M, Falcone G. DNA restriction fragments length polymorphism of Mycobacterium tuberculosis isolates in Pisa, Italy. Eur J Epidem 1997; 13: 845-851.
21. Safi H, Aznar J, Palomares J C. Molecular epidemiology of Mycobacterium tuberculosis strains isolated during a 3-years period (1993 to 1995) in Seville, Spain. J Clin Microbiol 1997; 35: 2472-2476.
22. Gutierrez M C, Vincent V, Aubert D, et al. Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France and surrounding area. J Clin Microbiol 1998; 36: 486-492.
23. Van Deutekom H, Gerritsen J J J, Van Soolingen D, Vanameijden E J C, Van Embden J D A, Coutinho R A. Molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 1997; 25: 1071-1077.
24. Kubin M, Riley L W, Havelkova M, Poltoratskaia N, Kocova A. Molecular epidemiology of tuberculosis in Prague: analysis by restriction fragment length polymorphism. Int J Infect Dis 1998; 2: 155-158.
25. Genewein A, Telenti A, Bernasconi C, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993; 342: 841-844.
26. Poulsen S, Bauer J, Kok-Jensen A. Transmission of tuberculosis in Copenhagen, Denmark. Int J Tuberc Lung Dis 1998; 2 (Suppl 2): S313.
27. Nordtvedt S, Gulsvik A, Hexeberg A, Hofstad T, Caugant D A. Tuberkulose i Bergen i 1996. Tidsskr Nor Laegeforen 1999; 119: 30-33 (in Norwegian with English summary).
28. MSIS-rapport 44/1997 (in Norwegian). Reporting system for communicable diseases. National Institute of Public Health. Oslo, Norway.
29. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
30. Glynn J R, Vynnycky E, Fine P E M. Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999; 149: 366-371.
31. Alito A, Morcillo N, Scipioni S, et al. The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation. J Clin Microbiol 1999; 37: 788-791 .
32. Braden C R, Templeton G E, Cave M D, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997; 175: 1446-1452.
33. Toman K. Tuberculosis case-finding and chemotherapy. WHO/ Geneva 1979: 28-37.
34. Springett V H. Results of the study on X-ray readings of the ad hoc committee for the study of classification and terminology in tuberculosis. Bull Int Union Tuberc 1968; 41: 107-109.
35. Jentoft H F, Omenaas E, Eide G E, Gulsvik A. Tuberculin test variability: using the Norwegian Adrenaline-Pirquet method. Int J Tuberc Lung Dis 1999; 3: 326-329.